A new twist to adaptor proteins contributes to regulation of lymphocyte cell signaling

Trends in Immunology

Volumn 29, Issue 8, 2008, Pages 388-396

  Isakov, Noah ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CRK LIKE PROTEIN; PEPTIDYLPROLYL ISOMERASE;

CONFORMATION; ENZYME REGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW;

ANIMALS; HUMANS; LYMPHOCYTES; PEPTIDYLPROLYL ISOMERASE; PROTO-ONCOGENE PROTEINS C-CRK; SIGNAL TRANSDUCTION;

EID: 47749132965     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.04.006     Document Type: Review

References (70)

1. Pawson T., and Gish G.D. SH2 and SH3 domains: from structure to function. Cell 71 (1992) 359-362
2. Pawson T. SH2 and SH3 domains in signal transduction. Adv. Cancer Res. 64 (1994) 87-110
3. Seet B.T., et al. Reading protein modifications with interaction domains. Nat. Rev. Mol. Cell Biol. 7 (2006) 473-483
4. Feller S.M. Crk family adaptors-signalling complex formation and biological roles. Oncogene 20 (2001) 6348-6371
5. Gelkop S., et al. Involvement of crk adapter proteins in regulation of lymphoid cell functions. Immunol. Res. 28 (2003) 79-91
6. Muralidharan V., et al. Solution structure and folding characteristics of the C-terminal SH3 domain of c-Crk-II. Biochemistry 45 (2006) 8874-8884
7. Smith J.J., et al. Apoptotic regulation by the Crk adapter protein mediated by interactions with Wee1 and Crm1/exportin. Mol. Cell. Biol. 22 (2002) 1412-1423
8. Ogawa S., et al. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells. Oncogene 9 (1994) 1669-1678
9. Guris D.L., et al. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat. Genet. 27 (2001) 293-298
10. Moon A.M., et al. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev. Cell 10 (2006) 71-80
11. Park T.J., et al. Cardiovascular and craniofacial defects in Crk-null mice. Mol. Cell. Biol. 26 (2006) 6272-6282
12. Swaminathan G., and Tsygankov A.Y. The Cbl family proteins: ring leaders in regulation of cell signaling. J. Cell. Physiol. 209 (2006) 21-43
13. Ryan P.E., et al. Regulating the regulator: negative regulation of Cbl ubiquitin ligases. Trends Biochem. Sci. 31 (2006) 79-88
14. Sawasdikosol S., et al. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J. Biol. Chem. 270 (1995) 2893-2896
15. Reedquist K.A., et al. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J. Biol. Chem. 271 (1996) 8435-8442
16. Sawasdikosol S., et al. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation. J. Immunol. 157 (1996) 110-116
17. Buday L., et al. Interactions of Cbl with two adapter proteins, Grb2 and Crk, upon T cell activation. J. Biol. Chem. 271 (1996) 6159-6163
18. Gelkop S., et al. T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidylinositol 3-kinase (p85) via a complex mechanism involving the Cbl protein. J. Biol. Chem. 276 (2001) 36174-36182
19. Zhang W., et al. Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b. J. Biol. Chem. 278 (2003) 23978-23983
20. Petruzzelli L., et al. Adhesion through the interaction of lymphocyte function-associated antigen-1 with intracellular adhesion molecule-1 induces tyrosine phosphorylation of p130cas and its association with c-CrkII. J. Biol. Chem. 271 (1996) 7796-7801
21. Kanda H., et al. Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL, a member of the p130Cas-related docking protein family, and its subsequent binding to the Src homology 2 domain of c-Crk. Eur. J. Immunol. 27 (1997) 2113-2117
22. Ohashi Y., et al. Tyrosine phosphorylation of Crk-associated substrate lymphocyte-type is a critical element in TCR- and beta 1 integrin-induced T lymphocyte migration. J. Immunol. 163 (1999) 3727-3734
23. Ohashi Y., et al. T cell receptor-mediated tyrosine phosphorylation of Cas-L, a 105-kDa Crk-associated substrate-related protein, and its association of Crk and C3G. J. Biol. Chem. 273 (1998) 6446-6451
24. Nishihara H., et al. DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines. Blood 100 (2002) 3968-3974
25. Ling P., et al. Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase. Mol. Cell. Biol. 19 (1999) 1359-1368
26. Gelkop S., and Isakov N. T cell activation stimulates the association of enzymatically active tyrosine-phosphorylated ZAP-70 with the Crk adapter proteins. J. Biol. Chem. 274 (1999) 21519-21527
27. Gelkop S., et al. T cell activation-induced CrkII binding to the Zap70 protein tyrosine kinase is mediated by Lck-dependent phosphorylation of Zap70 tyrosine 315. J. Immunol. 175 (2005) 8123-8132
28. Oda A., et al. CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. Blood 97 (2001) 2633-2639
29. Sasahara Y., et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol. Cell 10 (2002) 1269-1281
30. Martelli M.P., et al. T cell regulation of p62(dok) (Dok1) association with Crk-L. J. Biol. Chem. 276 (2001) 45654-45661
31. Boussiotis V.A., et al. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 278 (1997) 124-128
32. Ichiba T., et al. Enhancement of guanine-nucleotide exchange activity of C3G for Rap1 by the expression of Crk, CrkL, and Grb2. J. Biol. Chem. 272 (1997) 22215-22220
33. Peterson A.C., et al. T cell development and function in CrkL-deficient mice. Eur. J. Immunol. 33 (2003) 2687-2695
34. Feller S.M., et al. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13 (1994) 2341-2351
35. Ren R., et al. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8 (1994) 783-795
36. de Jong R., et al. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site. Oncogene 14 (1997) 507-513
37. Songyang Z., et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72 (1993) 767-778
38. Rosen M.K., et al. Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 374 (1995) 477-479
39. Anafi M., et al. A potential SH3 domain-binding site in the Crk SH2 domain. J. Biol. Chem. 271 (1996) 21365-21374
40. Nichols G.L., et al. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood 84 (1994) 2912-2918
41. ten Hoeve J., et al. Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. Blood 84 (1994) 1731-1736
42. Oda T., et al. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J. Biol. Chem. 269 (1994) 22925-22928
43. Schiene C., and Fischer G. Enzymes that catalyse the restructuring of proteins. Curr. Opin. Struct. Biol. 10 (2000) 40-45
44. Barik S. Immunophilins: for the love of proteins. Cell. Mol. Life Sci. 63 (2006) 2889-2900
45. Schreiber S.L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251 (1991) 283-287
46. Ranganathan R., et al. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 89 (1997) 875-886
47. Brazin K.N., et al. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1899-1904
48. Colgan J., et al. Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity 21 (2004) 189-201
49. Ching K.A., et al. TCR/CD3-Induced activation and binding of Emt/Itk to linker of activated T cell complexes: requirement for the Src homology 2 domain. J. Immunol. 165 (2000) 256-262
50. Mallis R.J., et al. Structural characterization of a proline-driven conformational switch within the Itk SH2 domain. Nat. Struct. Biol. 9 (2002) 900-905
51. Pletneva E.V., et al. Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide. J. Mol. Biol. 357 (2006) 550-561
52. Breheny P.J., et al. Ligand specificity modulated by prolyl imide bond Cis/Trans isomerization in the Itk SH2 domain: a quantitative NMR study. J. Am. Chem. Soc. 125 (2003) 15706-15707
53. Yu L., et al. Regulation of Bruton tyrosine kinase by the peptidylprolyl isomerase Pin1. J. Biol. Chem. 281 (2006) 18201-18207
54. Esnault S., et al. The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. J. Immunol. 177 (2006) 6999-7006
55. Esnault S., et al. Pin1 modulates the type 1 immune response. PLoS ONE 2 (2007) e226
56. Shen Z.J., et al. Pin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J. Clin. Invest. 118 (2008) 479-490
57. Saitoh T., et al. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7 (2006) 598-605
58. Shaw P.E. Peptidyl-prolyl isomerases: a new twist to transcription. EMBO Rep. 3 (2002) 521-526
59. Lu K.P., et al. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 12 (2002) 164-172
60. Monje P., et al. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 280 (2005) 35081-35084
61. Sarkar P., et al. Proline cis-trans isomerization controls autoinhibition of a signaling protein. Mol. Cell 25 (2007) 413-426
62. Harkiolaki M., et al. The C-terminal SH3 domain of CRKL as a dynamic dimerization module transiently exposing a nuclear export signal. Structure 14 (2006) 1741-1753
63. Kobashigawa Y., et al. Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat. Struct. Mol. Biol. 14 (2007) 503-510
64. Lu K.P., et al. Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol. 3 (2007) 619-629
65. Shaw P.E. Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?. EMBO Rep. 8 (2007) 40-45
66. Esnault S., et al. Pinning down signaling in the immune system: the role of the peptidyl-prolyl isomerase pin1 in immune cell function. Crit. Rev. Immunol. 28 (2008) 45-60
67. Liu J., et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991) 807-815
68. McCaffrey P.G., et al. NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J. Biol. Chem. 268 (1993) 3747-3752
69. Zhou X.Z., et al. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism. Cell. Mol. Life Sci. 56 (1999) 788-806
70. Delano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific